RhumbLine Advisers’s MDxHealth MDXH Stock Holding History

RhumbLine Advisers’s Portfolio MDXH Stock Details MDXH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-72	Closed	-$257	–	4142
2025 Q4	$257	Hold	72	–	–	﹤0.01%	4078
2025 Q3	$334	Hold	72	–	–	﹤0.01%	4070
2025 Q2	$159	Hold	72	–	–	﹤0.01%	4099
2025 Q1	$102	Hold	72	–	–	﹤0.01%	4099
2024 Q4	$170	Hold	72	–	–	﹤0.01%	4126
2024 Q3	$149	Hold	72	–	–	﹤0.01%	4159
2024 Q2	$172	Hold	72	–	–	﹤0.01%	4325
2024 Q1	$186	Hold	72	–	–	﹤0.01%	4220
2023 Q4	$283	Hold	72	–	–	﹤0.01%	4224
2023 Q3	$204	Hold	72	–	–	﹤0.01%	4267
2023 Q2	$245	Buy	+72	New	+$263	﹤0.01%	4349

Other funds holding MDXH

Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

MVM Partners Boston, Massachusetts $10.8M AUM 61.97% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Samjo Management New York $231M AUM 13.04% 1-Year Est. Return

MBAM

Mink Brook Asset Management West Palm Beach, Florida $179M AUM 37.68% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

RhumbLine Advisers's MDXH Position: Q1 2026 in Review

RhumbLine Advisers sold out of MDxHealth (MDXH) in Q1 2026, closing a stake of 72 shares — an estimated $257 sold.

RhumbLine Advisers first reported a position in MDXH in Q2 2023 and held it in 11 quarters. The position peaked at $334 in Q3 2025. 51 funds tracked by Wall St. Rank hold MDXH as of Q1 2026.

RhumbLine Advisers reported no remaining MDxHealth position as of Q1 2026 after selling out during the quarter.
RhumbLine Advisers sold 72 MDxHealth shares in Q1 2026, an estimated $257.
RhumbLine Advisers first reported a position in MDxHealth in Q2 2023 and held it in 11 quarters.
RhumbLine Advisers's MDxHealth position peaked at $334 in Q3 2025.
51 funds tracked by Wall St. Rank held MDxHealth as of Q1 2026.

Based on RhumbLine Advisers's 13F filing for Q1 2026, filed 12 May 2026.